Hormones dans les Protéines Recombinantes

<p>Applications Testosterone Heptanoate-6,6,7,7,7-d5 (CAS# 1263095-31-3) is a useful isotopically labeled research compound.<br></p>

<p>Applications A labelled steroid hormone with weak androgenic activity. It is metabolized from Testosterone (T155000) in the liver and is used in doping analysis to detect testosterone misuse. Controlled Substance.<br>References Park, J., et al.: J. Anal. Toxicol., 14, 66 (1990),; Palonek, E., et al.: J. Steroid Mol. Biol., 55, 121 (1995); Aguilera, R., et al.: Clin. Chem. 47, 292 (2001); Flenker, U., et al.: Steroids, 73, 408 (2008); Saudan, C. et al.: Steroids, 70, 179 (2005);<br></p>

<p>Insulin Porcine is a two chain, glycosylated polypeptide chain containing 51 amino acids and having a molecular mass of 5777 Dalton.  The a and b chains are joined by two interchain disulfide bonds with the a chain containing an intrachain disulfide bond. Insulin regulates the cellular uptake, utilization, and storage of glucose, amino acids, and fatty acids and inhibits the breakdown of glycogen, protein, and fat.</p>

<p>Follicle Stimulating Hormone (FSH) is a protein hormone that plays a crucial role in the reproductive cycle. It stimulates the growth and development of follicles in the ovaries, which produce estrogen and progesterone. FSH also regulates spermatogenesis in men. Studies have shown that FSH has inhibitory activity on cyclin-dependent kinases, which are enzymes that regulate the cell cycle. This inhibitory activity leads to decreased cell proliferation and growth, making it a potential treatment for cancer. In vitro studies have demonstrated its effectiveness against breast and lung cancer cells lines when combined with kinase inhibitors. Additionally, FSH has been found to stimulate protein kinase activity, which may be useful in developing therapies for other diseases such as diabetes and osteoporosis.</p>

<p>Erythropoietin is a hormone that stimulates the production of red blood cells, and is used for patients with anemia. It is a recombinant human erythropoietin (rhEPO) that has been produced by genetic engineering. Erythropoietin binds to receptors on the surface of many types of cells, including those in the bone marrow. This binding stimulates the production of red blood cells from precursor cells in the bone marrow, and increases oxygen-carrying capacity in blood. The half-life of erythropoietin is approximately 36 hours. This drug also can be used to reduce high blood pressure and improve responsiveness to other drugs that are given intravenously. Erythropoietin can cause an increase in asialoglycoprotein levels in serum, which may be due to its effects on hepatocytes or erythrocytes.</p>

<p>Expression system: HEK294 Cells&lt;br&gt;Length: 27-217, Full Length of Mature Protein&lt;br&gt;Activity: Not Tested</p>